Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

UK pharma apprehensive about post-Brexit investment

ABPI calls for a return of the 'white heat' of innovation to the UK

Sanofi reception

Sanofi agrees €250m diabetes deal with AI firm Exscientia

The French pharma giant will pay royalties and contribute research funding

- PMLiVE

Uniphar acquires specialist sales firm OUTiCO

It will continue to be led by founders Paul Black and Mike Cooper

- PMLiVE

Activists torpedo Immunomedics deal with Seattle Genetics

venBio says deal will enrich CEO at shareholders' expense

Perfect Timing?

Timing is often the reason for embracing a new approach "this is ideal timing for our strategic planning", yet can also be a major barrier for doing more of the same...

Lucid Group Communications Limited

- PMLiVE

FDA clears new ALS drug Radicava ahead of schedule

MT Pharma’s medicine will soon offer US patients an alternative to Sanofi’s Rilutek

- PMLiVE

Teva drops laquinimod for most common form of MS after failed trial

CONCERTO study showed no disability progression improvements over placebo

- PMLiVE

Digital behavioural health firm Ieso expands executive leadership team

Appoints Gidget Madix and Craig Gravina

- PMLiVE

Helen Parfitt joins Research Partnership

She takes on role as head of its Therapy Watch market tracking tool

Stop marking your own homework

The value of external brand plan assessment

20 questions: Round 2

As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What do you love about your job?"Watch the video: http://bit.ly/2qA1oP9

Inizio

- PMLiVE

WHO pilots scheme to make biosimilars available to poorer countries

Plans to expand prequalification scheme to medicines such as Roche’s Rituxan and Herceptin

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links